nitroxoline has been researched along with Multiple Myeloma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Hu, T; Jiang, H; Jiang, X; Luo, C; Luo, X; Qiao, G; Shen, J; Wang, J; Wang, X; Xing, J; Yang, F; Zhang, R; Zheng, M | 1 |
| Chen, W; Li, J; Liu, X; Shi, J; Zhang, Z; Zhao, L; Zhou, Y | 1 |
| Cao, B; Du, Y; Mao, H; Mao, X; Zhang, Z; Zhao, J; Zhou, H | 1 |
1 review(s) available for nitroxoline and Multiple Myeloma
| Article | Year |
|---|---|
A review on the treatment of multiple myeloma with small molecular agents in the past five years.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Combined Modality Therapy; Deubiquitinating Enzymes; Drug Development; Drug Resistance; Histone Deacetylases; Humans; Ikaros Transcription Factor; Immunomodulating Agents; Models, Molecular; Morpholines; Multiple Myeloma; Phthalimides; Piperidones; Proteasome Inhibitors; Treatment Outcome; Ubiquitin-Protein Ligases | 2022 |
2 other study(ies) available for nitroxoline and Multiple Myeloma
| Article | Year |
|---|---|
Rational design of 5-((1H-imidazol-1-yl)methyl)quinolin-8-ol derivatives as novel bromodomain-containing protein 4 inhibitors.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Computer-Aided Design; Drug Design; Humans; Imidazoles; Leukemia; Multiple Myeloma; Nitroquinolines; Nuclear Proteins; Proto-Oncogene Proteins c-myc; Quinolines; Structure-Activity Relationship; Transcription Factors; Triple Negative Breast Neoplasms | 2019 |
Nitroxoline shows antimyeloma activity by targeting the TRIM25/p53 axle.
Topics: A549 Cells; Animals; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Multiple Myeloma; Nitroquinolines; Off-Label Use; Random Allocation; Transcription Factors; Tripartite Motif Proteins; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2017 |